BIOMARIN PHARMACEUTICAL INC (BMRN) › EPS (Basic)BIOMARIN PHARMACEUTICAL INC (BMRN) — EPS (Basic)Annual figures by period end, from SEC filings.2008-12-31: $0.312009-12-31: $0.002010-12-31: $2.002011-12-31: $-0.482012-12-31: $-0.952014-12-31: $-0.922015-12-31: $-1.072016-12-31: $-3.802017-12-31: $-0.672018-12-31: $-0.442019-12-31: $-0.132020-12-31: $4.722021-12-31: $-0.352022-12-31: $0.762023-12-31: $0.892024-12-31: $2.252025-12-31: $1.82$1.822008-12-31EPS (Basic) (USD/shares)2025-12-31Period endedEPS (Basic)Change YoYSource filing2025-12-31$1.82-19.1%2026-02-26From 2025-01-012024-12-31$2.25+152.8%2026-02-26From 2024-01-012023-12-31$0.89+17.1%2026-02-26From 2023-01-012022-12-31$0.76—2025-02-24From 2022-01-012021-12-31$-0.35-107.4%2024-02-26From 2021-01-012020-12-31$4.72—2023-02-27From 2020-01-012019-12-31$-0.13—2022-02-25From 2019-01-012018-12-31$-0.44—2021-02-26From 2018-01-012017-12-31$-0.67—2020-02-27From 2017-01-012016-12-31$-3.80—2019-02-28From 2016-01-012015-12-31$-1.07—2018-02-26From 2015-01-012014-12-31$-0.92—2017-02-27From 2014-01-012012-12-31$-0.95—2013-02-26From 2012-01-012011-12-31$-0.48-124.0%2013-02-26From 2011-01-012010-12-31$2.00—2013-02-26From 2010-01-012009-12-31$0.00-100.0%2012-02-22From 2009-01-012008-12-31$0.31—2011-02-24From 2008-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted Shares